A multicentre randomised phase III study of low-dose thalidomide, prednisolone and zoledronic acid versus prednisolone and zoledronic acid to assess survival post-ASCT maintenance therapy in patients with multiple myeloma (MM06)
收藏Research Data Australia2024-08-03 收录
下载链接：
https://researchdata.edu.au/a-multicentre-randomised-myeloma-mm06/2538273
下载链接
链接失效反馈官方服务：
资源简介：
Dataset includes: Data for 269 patients with newly diagnosed multiple myeloma using low-dose thalidomide, prednisolone and zoledronic acid versus prednisolone and zoledronic acid in a randomised trial Demographic data, diagnostic data, treatment data, outcome data
提供机构：
Health Data Australia Contributor Records
